Information Provided By:
Fly News Breaks for June 15, 2018
Jun 15, 2018 | 07:02 EDT
Cantor Fitzgerald analyst William Tanner raised his price target for Prothena to $18 citing his analysis of the potential value of the company's drug discovery platform and management's recently announced restructuring plan. The analyst reiterates a Overweight rating on the shares.
News For PRTA From the Last 2 Days
There are no results for your query PRTA